You need a license to cut-and-paste this copyrighted news content.
Use this link to purchase your paid subscription ($200/year for individuals and $1,000/year for companies of every size): https://endpts.com/subscribe
Already a paid subscriber? Sign in to Endpoints News to remove this message.
An active pharmaceutical ingredient manufacturer in China has come under scrutiny for the latest deadly industrial accident after an explosive accident at its plant killed 10 workers.
Qilu Tianhe Huishi Pharmaceutical, operating in Shandong province on the east coast of China, exports generic drugs like amikacin and tazobactam in bulk to Europe, North and South America and the Middle East. Regulators at the National Medicinal Products Administration have previously named the company for failing quality inspections.
China’s emergency management ministry has sent a team to assist local authorities in an investigation, according to state news agency Xinhua, which reported that workers died from smoke inhalation after sparks from a pipe they were welding ignited a heat-transferring substance.